CVE-2018-10631

Exploitation

Assessed, none found. CISA's assessment recorded neither public exploit code nor evidence of exploitation when it was made.

SSVC decision

• ExploitationnoneCISA recorded no public exploit code and no evidence of exploitation.
• AutomatablenoAt least one step from reconnaissance to exploitation cannot be reliably automated.
• Technical ImpacttotalSuccessful exploitation gives total control of the vulnerable component.

CISA publishes the decision points, not a final SSVC decision. The decision also depends on mission and well-being impact, which is a property of your deployment rather than of the vulnerability.

EPSS probability

0.41% probability of exploitation activity in the next 30 days.

EPSS percentile

Equal to or higher than the score of 35.0% of scored records. A rank, not a probability.

NVD base score

6.8 (CVSS v3.x), scored by the NVD independently of the CNA.

NVD CVSS vector

CVSS:3.0/AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

NVD analysis status

Modified. NVD last modified this record on 2026-06-17.

Red Hat severity

No Red Hat rating. Red Hat rates the CVEs that affect its products.

Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.

Published

2018-07-13 19:00Z8 YR AGO

Last updated

2025-08-26 14:26Z1 YR AGO

Reserved

2018-05-01

Assigning CNA

icscert

Record state

PUBLISHED

Severity

Medium (CVSS 6.3)

CNA CVSS vector

CVSS:3.1/AV:P/AC:H/PR:N/UI:R/S:U/C:H/I:H/A:H

Weaknesses

• CWE-693Protection Mechanism FailurePillar

Data version

5.1

Document digest

45ac8757b23e68cd33f9e7341e5ef3ee6f84a8aafa7788326c64251336b96186

• global.medtronic.comhttps://global.medtronic.com/xg-en/product-security/security-bulletins/nvision.html
• www.medtronic.comhttps://www.medtronic.com/security
• ics-cert.us-cert.govhttps://ics-cert.us-cert.gov/advisories/ICSMA-18-137-01
• www.securityfocus.comhttp://www.securityfocus.com/bid/104213